Jaspreet Jain

New Delhi, DL 110067, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Bivalent SMAC mimetic APG-1387 reduces HIV reservoirs and limits viral rebound in humanized mice.

Bivalent SMAC mimetic APG-1387 reduces HIV reservoirs and limits viral rebound in humanized mice.

Journal: iScience
Published: June 21, 2024

The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023.

The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: July 04, 2023

Erratum for Essalmani et al., "Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity".

Erratum for Essalmani et al., "Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity".

Journal: Journal of virology
Published: June 06, 2022

Concurrent dengue infections: Epidemiology & clinical implications.

Concurrent dengue infections: Epidemiology & clinical implications.

Journal: The Indian journal of medical research
Published: May 09, 2022

MiRNA-103 downmodulates CCR5 expression reducing human immunodeficiency virus type-1 entry and impacting latency establishment in CD4+ T cells.

MiRNA-103 downmodulates CCR5 expression reducing human immunodeficiency virus type-1 entry and impacting latency establishment in CD4+ T cells.

Journal: iScience
Published: April 14, 2022

Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.

Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.

Journal: Journal of virology
Published: March 28, 2022

L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection.

L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection.

Journal: Nutrients
Published: March 15, 2021

Chikungunya virus molecular evolution in India since its re-emergence in 2005.

Chikungunya virus molecular evolution in India since its re-emergence in 2005.

Journal: Virus evolution
Published: December 30, 2020

Chikungunya Outbreaks in India: A Prospective Study Comparing Neutralization and Sequelae during Two Outbreaks in 2010 and 2016.

Chikungunya Outbreaks in India: A Prospective Study Comparing Neutralization and Sequelae during Two Outbreaks in 2010 and 2016.

Journal: The American journal of tropical medicine and hygiene
Published: February 19, 2020

Establishment and Comparison of Pathogenicity and Related Neurotropism in Two Age Groups of Immune Competent Mice, C57BL/6J Using an Indian Isolate of Chikungunya Virus (CHIKV).

Establishment and Comparison of Pathogenicity and Related Neurotropism in Two Age Groups of Immune Competent Mice, C57BL/6J Using an Indian Isolate of Chikungunya Virus (CHIKV).

Journal: Viruses
Published: March 01, 2019

In Vivo Evaluation of Withania somnifera-Based Indian Traditional Formulation ( Amukkara Choornam), Against Chikungunya Virus-Induced Morbidity and Arthralgia.

In Vivo Evaluation of Withania somnifera-Based Indian Traditional Formulation ( Amukkara Choornam), Against Chikungunya Virus-Induced Morbidity and Arthralgia.

Journal: Journal of evidence-based integrative medicine
Published: February 28, 2018

Antiviral activity of ethanolic extract of Nilavembu Kudineer against dengue and chikungunya virus through in vitro evaluation.

Antiviral activity of ethanolic extract of Nilavembu Kudineer against dengue and chikungunya virus through in vitro evaluation.

Journal: Journal of Ayurveda and integrative medicine
Published: February 16, 2018
Showing 1-12 of 23

Last Updated: 09/26/2026